Phibro Animal Health (PAHC) Operating Income Growth (1y) (2013 - 2026)
Phibro Animal Health (PAHC) Operating Income Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.88 Bn | 32.14 Bn | 1.97 Bn | 25.63% |
| 3 | Zoetis | 32.64 Bn | 30.70 Bn | 1.62 Bn | -1.30% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -319.32% |
| 5 | United Therapeutics | 23.04 Bn | 20.88 Bn | 648.10 Mn | -14.89% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.37 Bn | 18.57 Bn | 1.16 Bn | 97.23% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.45 Bn | 800.70 Mn | 719.49% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 21.25% |
| 10 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 125.68 Mn | 33.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.23% |
| Dec 31, 2025 | 97.10% |
| Sep 30, 2025 | 189.62% |
| Jun 30, 2025 | 83.09% |
| Mar 31, 2025 | 68.21% |
| Dec 31, 2024 | 62.62% |
| Sep 30, 2024 | 2,537.88% |
| Jun 30, 2024 | -22.51% |
| Mar 31, 2024 | 7.39% |
| Dec 31, 2023 | -0.90% |
| Sep 30, 2023 | -105.31% |
| Jun 30, 2023 | 3.85% |
| Mar 31, 2023 | -3.34% |
| Dec 31, 2022 | -28.93% |
| Sep 30, 2022 | -6.35% |
| Jun 30, 2022 | 19.46% |
| Mar 31, 2022 | -4.66% |
| Dec 31, 2021 | 12.09% |
| Sep 30, 2021 | -6.86% |
| Jun 30, 2021 | 5.73% |